Medical Developments shares move higher on strong earnings release

The Medical Developments International Ltd (ASX: MVP) share price is on the move today following the release of its half-year earnings.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medical Developments International Ltd (ASX: MVP) share price is on the move today following the release of the company's half-year earnings.

Medical Developments shares were down by as much as 5.72% this morning but have since recovered to be up by 1.29% at the time of writing.

Net profit jumps higher

For the half year ended 31 December 2019, Medical Developments announced an 82% increase in net profit after tax to $240,000. This is up from the $132,000 that it recorded in 1H19.

Meanwhile, gross revenue for the period came in at $11.2 million, up 15% from $9.8 million in the prior corresponding period (pcp). Gross margins remain strong and largely consistent with the prior year at 67%, while earnings before interest, tax, depreciation and amortisation (EBITDA) was up 21% to $1.5 million.

Revenue from the company's Penthrox offering was reported to be continuing to grow strongly with multiple international launches still to occur. To date, Penthrox has launched in-market in the UK and Ireland as well as 15 countries across Europe including France, Belgium, Sweden, and Denmark.

Strong global sales growth

Global gross sales were up 17%, driven by growth within the company's Pharmaceutical and Medical segments.

Medical Developments recorded strong growth in its range of respiratory device sales, driven by the performance of North America which saw a massive 88% jump in sales. Additionally, Australia saw sales growth of 44% in this segment while Europe and the UK sales were up 73%.

Increase in operating expenses

Operating expenses increased 15% during the half year. The company noted that this rise was due to increased "pharmacovigilance" cost as a result of expanding geographic sales for Penthrox and Medical Devices, as well as non-cash share-based payments, non-cash depreciation expenses, and non-cash foreign exchange loss compared to the pcp.

The company also increased its investment in research and development during the period which further weighed down operating expenses.

12-month outlook

Over the next 12 months, the company expects to complete the roll-out of Penthrox into remaining European Union countries, Mexico, Iran, Jordan, South Korea and Thailand.

In addition, Medical Developments plans to consolidate and grow its Respiratory Device sales in the USA, Europe and elsewhere.

Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Medical Developments International Limited. The Motley Fool Australia has recommended Medical Developments International Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Ten smiling business people wave to the camera after receiving some winning company news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a nervous, but positive, Tuesday for ASX investors.

Read more »

A susccesful person kicks back and relaxes on a comfy chair
Best Shares

If I could only buy and hold a single ASX share forever, it would be this one

There are two reasons why this stock is my first choice...

Read more »

young woman reviewing financial reports at desk with multiple computer screens
Opinions

Brokers' verdict on 4 popular ASX 200 financial stocks

Financials outperformed every other sector in FY25. What should you do now with these 4 stocks?

Read more »

two colleagues high five each other as they sit side by side at a long desk in front of their laptop computers in an office environment.
Share Gainers

Why Bapcor, Ramelius, Sandfire, and WIA Gold shares are rising today

These shares are having a better day than most on Tuesday. But why?

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Share Market News

Is it too late to invest in the record setting S&P 500 stock gains?

A top broker reveals what to expect next from the surging S&P 500 Index.

Read more »

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Share Fallers

Why Boss Energy, DroneShield, Greatland, and Viva Energy shares are tumbling today

Let's see why these shares are out of favour with investors on Tuesday.

Read more »

Man smiling at a laptop because of a rising share price.
Broker Notes

4 ASX shares to buy this week: experts

Looking for investment inspiration?

Read more »

Miner and company person analysing results of a mining company.
Energy Shares

Should you buy Boss Energy shares now after Monday's huge sell-off?

Macquarie gives its verdict on Boss Energy shares following Monday’s crash.

Read more »